Prospect of Using Cell Product for the Therapy of Skin Defects in Diabetes Mellitus
- Авторлар: Lykov A.1,2, Bondarenko N.1,2, Poveshchenko O.1,2, Miller T.1, Poveshchenko A.1,2, Surovtseva M.1,2, Bgatova N.1, Konenkov V.1
-
Мекемелер:
- Research Institute of Clinical and Experimental Lymphology
- E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation
- Шығарылым: Том 164, № 2 (2017)
- Беттер: 266-268
- Бөлім: Translated from Kletochnye Tekhnologii v Biologii i Meditsine (Cell Technologies in Biology and Medicine)
- URL: https://journals.rcsi.science/0007-4888/article/view/239545
- DOI: https://doi.org/10.1007/s10517-017-3970-0
- ID: 239545
Дәйексөз келтіру
Аннотация
The effectiveness of autologous cell product in the therapy of skin burn wounds was studied in C57B1/6 male mice against the background of streptozotocin-induced diabetes mellitus. In animals with and without modeled diabetes mellitus, significant decrease in skin defect area was observed after single administration of the cell product (bone marrow multipotent mesenchymal stromal cells, fibroblasts or media conditioned by these cells).
Авторлар туралы
A. Lykov
Research Institute of Clinical and Experimental Lymphology; E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation
Хат алмасуға жауапты Автор.
Email: aplykov2@mail.ru
Ресей, Novosibirsk; Novosibirsk
N. Bondarenko
Research Institute of Clinical and Experimental Lymphology; E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
Ресей, Novosibirsk; Novosibirsk
O. Poveshchenko
Research Institute of Clinical and Experimental Lymphology; E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
Ресей, Novosibirsk; Novosibirsk
T. Miller
Research Institute of Clinical and Experimental Lymphology
Email: aplykov2@mail.ru
Ресей, Novosibirsk
A. Poveshchenko
Research Institute of Clinical and Experimental Lymphology; E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
Ресей, Novosibirsk; Novosibirsk
M. Surovtseva
Research Institute of Clinical and Experimental Lymphology; E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
Ресей, Novosibirsk; Novosibirsk
N. Bgatova
Research Institute of Clinical and Experimental Lymphology
Email: aplykov2@mail.ru
Ресей, Novosibirsk
V. Konenkov
Research Institute of Clinical and Experimental Lymphology
Email: aplykov2@mail.ru
Ресей, Novosibirsk
![](/img/style/loading.gif)